

Designed to accelerate agentic drug discovery pipelines in the Bio ecosystem and beyond, NeuroLab AI uses a proprietary collection of neural networks to predict the cognitive, molecular, and functional effects of any known or novel chemical compound on the human brain. Trained on a state-of-the-art biomedical knowledge graph consisting of 150,000+ nodes and over 8 million edges, NeuroLab AI produces multi-scale human and machine-readable output encompassing +400 neuroanatomical regions.
How do you feel about NeuroLab AI?
Nootropics DAO's current core contributor backgrounds include decades of combined experience in clinical neuroscience, systems engineering and formal verification, growth marketing, and more. With multiple publications in top academic journals plus years spent inside biohacking communities, DAO contributors bring a unique blend of perspective and rigor to citizen science.
Nootropics DAO's current core contributor backgrounds include decades of combined experience in clinical neuroscience, systems engineering and formal verification, growth marketing, and more. With multiple publications in top academic journals plus years spent inside biohacking communities, DAO contributors bring a unique blend of perspective and rigor to citizen science.
NeuroLab: Atlas
A free user tier with 50 fully addressable data sets and interactive knowledge graph exploration.
NeuroLab: Axon
Versioned APIs, MCP agent access, per-section report payments, and third-party tool integrations.
NeuroLab: Frontier
Novel-structure and peptide inference, expanded pharmacology, and provenance-bound evidence intake.
NeuroLab: Workbench
Personal libraries, saved subgraphs, compound cohorts, and hypothesis and publication drafting.
NeuroLab: Cortex
Typed causal state, branch-preserving and abductive reasoning, multiscale whole-brain mapping.
NeuroLab: Commons
Community compound submission, prioritisation voting, and shared IP terms for novel candidates.
NeuroLab predicts which receptors a compound engages, then builds a mechanism out from there through cells, circuits, regions and into cognition.
Every step carries the papers behind it, drawn from ChEMBL, BindingDB, IUPHAR and open datasets. The brain view maps the result across 400 neuroanatomical regions.. Molecules nobody has published on get a prediction from structure alone.
Point a research agent at a compound and it gives you and it will give you a story that reads well. What it will not tell you is which link has a paper behind it and which one got filled in because the sentence needed finishing. The evidence is real and it exists, spread across pharmacology databases, brain atlases and forty years of papers, in formats that were never built to connect.
As the world's first DeSci agent to provide a state-of-the-art deterministic reasoning layer via neurosymbolic inference capabilities and multiple graph neural networks, Neurolab gives the Bio ecosystem the tools to build a truly open, resilient, crowdsourced drug discovery pipeline.
Professional researchers and citizen scientists gain access to high-dimensional, multi-scale forecasts with natural language analysis tools and comparative reporting across any portfolio of candidate molecules.

https://sciencedirect.com/science/article/pii/S2095177925003259

https://doi.org/10.1093/nsr/nwac035

https://doi.org/10.1038/s41593-022-01186-3

https://sciencedirect.com/science/article/pii/S1053811917306821

https://pmc.ncbi.nlm.nih.gov/articles/PMC4990127

https://nature.com/articles/s41551-024-01242-2

https://cell.com/molecular-cell/fulltext/S1097-2765(26)00470-3
10,000,000
Total SupplyIgnition sale | 6.67% |
Liquidity | 10% |
Reserve Liquidity | 15% |
BIO Treasury | 12.9% |
Advisors | 14.83% |
veBIO staker airdrop | 20% |
Project Treasury | 15.6% |
Team | 5% |
10,000,000
Total SupplyIgnition sale | 6.67% |
Liquidity | 10% |
Reserve Liquidity | 15% |
BIO Treasury | 12.9% |
Advisors | 14.83% |
veBIO staker airdrop | 20% |
Project Treasury | 15.6% |
Team | 5% |